Svenja Brakemeier

Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study

René Günther, Claudia D. Wurster, Svenja Brakemeier et al. · The Lancet Regional Health - Europe · 2024 · 61 citations · Full text

Medicine, Neurology, Pharmacotherapy +14

Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study

Astrid Pechmann, Max Behrens, Katharina Dörnbrack et al. · Orphanet Journal of Rare Diseases · 2022 · 40 citations · Full text

Medicine, Neurology, Pediatrics +14

Assessment of Bulbar Function in Adult Patients with 5q-SMA Type 2 and 3 under Treatment with Nusinersen

Svenja Brakemeier, Benjamin Stolte, Andreas Thimm et al. · Brain Sciences · 2021 · 27 citations · Full text

Medicine, Neurology, Neuroscience +17

Assessment of Health-Related Quality of Life in Adult Spinal Muscular Atrophy Under Nusinersen Treatment—A Pilot Study

Andreas Thimm, Svenja Brakemeier, Kathrin Kizina et al. · Frontiers in Neurology · 2022 · 27 citations · Full text

Medicine, Neurology, Functional Movement Assessment +13

Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder—Findings from the PARDIP study

Svenja Brakemeier, Andreas Sprenger, Inga Meyhöfer et al. · Bipolar Disorders · 2019 · 21 citations · Full text

Medicine, Neuroscience, Psychiatry +17